Nxera Pharma Co., Ltd. (SOLTF)
OTCMKTS · Delayed Price · Currency is USD
5.44
0.00 (0.00%)
Mar 5, 2026, 4:00 PM EST
Nxera Pharma Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -12,530 | -4,662 | -10,680 | 1,078 | 433 |
Depreciation & Amortization | 4,366 | 3,984 | 2,478 | 1,345 | 1,278 |
Loss (Gain) From Sale of Assets | - | - | - | - | 3,138 |
Asset Writedown & Restructuring Costs | 1,160 | - | - | - | - |
Loss (Gain) From Sale of Investments | - | 5 | 1,363 | 1,877 | -208 |
Loss (Gain) on Equity Investments | - | - | - | 429 | -50 |
Stock-Based Compensation | 1,953 | - | - | - | - |
Other Operating Activities | 3,940 | 28 | -942 | 338 | 486 |
Change in Accounts Receivable | -1,039 | -742 | 1,315 | -210 | -799 |
Change in Inventory | -2,456 | -5,935 | 1,908 | - | - |
Change in Accounts Payable | 2,971 | -487 | 1,552 | 315 | -184 |
Change in Unearned Revenue | -1,918 | - | - | - | - |
Change in Other Net Operating Assets | 885 | 91 | -2,267 | 4,780 | 3,001 |
Operating Cash Flow | -2,668 | -7,718 | -5,273 | 9,952 | 7,095 |
Operating Cash Flow Growth | - | - | - | 40.27% | 51.86% |
Capital Expenditures | -448 | -526 | -804 | -277 | -193 |
Cash Acquisitions | - | - | -62,941 | - | - |
Divestitures | - | - | - | - | 206 |
Sale (Purchase) of Intangibles | -177 | -1,011 | -47 | -26 | -8 |
Investment in Securities | 6,028 | -3,870 | - | 1,209 | - |
Other Investing Activities | 27 | 644 | 1 | 137 | 273 |
Investing Cash Flow | 5,430 | -4,763 | -63,791 | 1,043 | 278 |
Long-Term Debt Issued | - | - | 71,608 | - | 29,855 |
Long-Term Debt Repaid | -16,029 | -5,800 | -1,450 | - | - |
Total Debt Repaid | -16,029 | -5,800 | -1,450 | - | - |
Net Debt Issued (Repaid) | -16,029 | -5,800 | 70,158 | - | 29,855 |
Issuance of Common Stock | - | - | 9,983 | - | 600 |
Other Financing Activities | 1 | -1,054 | -31,812 | -4,887 | -19,332 |
Financing Cash Flow | -16,028 | -6,854 | 48,329 | -4,887 | 11,123 |
Foreign Exchange Rate Adjustments | 1,362 | 2,538 | 3,243 | 362 | 1,583 |
Miscellaneous Cash Flow Adjustments | 1 | - | - | - | - |
Net Cash Flow | -11,903 | -16,797 | -17,492 | 6,470 | 20,079 |
Free Cash Flow | -3,116 | -8,244 | -6,077 | 9,675 | 6,902 |
Free Cash Flow Growth | - | - | - | 40.18% | 50.70% |
Free Cash Flow Margin | -10.52% | -28.59% | -47.60% | 62.14% | 38.97% |
Free Cash Flow Per Share | -34.52 | -91.87 | -73.65 | 117.14 | 84.17 |
Cash Interest Paid | 531 | 435 | 241 | 171 | 157 |
Cash Income Tax Paid | -1,007 | 269 | 1,394 | 262 | -87 |
Levered Free Cash Flow | -4,841 | -9,249 | -11,530 | -1,367 | 8,544 |
Unlevered Free Cash Flow | -169.38 | -8,768 | -11,038 | -946.5 | 8,868 |
Change in Working Capital | -1,557 | -7,073 | 2,508 | 4,885 | 2,018 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.